Disparities in the presence of driver mutations and response to tyrosine kinase inhibitors in young patients with lung cancer

被引：0
|
作者：
Edwards, Kyle
Rose, Brandon
Lopes, Gilberto
Rodriguez, Estelamari
Olazagasti, Coral
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2024年 / 33卷 / 09期
关键词：
D O I：
10.1158/1538-7755.DISP24-A106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A106
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Zhang, Yan
    Wang, Zheng
    Hao, Xuezhi
    Hu, Xingsheng
    Wang, Hongyu
    Wang, Yan
    Ying, Jianming
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 18 - 24
  • [32] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Yan Zhang
    Zheng Wang
    Xuezhi Hao
    Xingsheng Hu
    Hongyu Wang
    Yan Wang
    Jianming Ying
    ChineseJournalofCancerResearch, 2017, 29 (01) : 18 - 24
  • [33] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    Gazdar, A. F.
    ONCOGENE, 2009, 28 : S24 - S31
  • [34] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    A F Gazdar
    Oncogene, 2009, 28 : S24 - S31
  • [35] Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome
    Looyenga, Brendan D.
    Cherni, Irene
    MacKeigan, Jeffrey P.
    Weiss, Glen J.
    TRANSLATIONAL ONCOLOGY, 2011, 4 (02): : 59 - 70
  • [36] Clinical development of Src tyrosine kinase inhibitors in lung cancer
    Lee, David
    Gautschi, Oliver
    CLINICAL LUNG CANCER, 2006, 7 (06) : 381 - 384
  • [37] EGFR tyrosine kinase inhibitors in lung cancer: An evolving story
    Sequist, Lecia V.
    Lynch, Thomas J.
    ANNUAL REVIEW OF MEDICINE, 2008, 59 : 429 - 442
  • [38] EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions
    Melosky, B.
    CURRENT ONCOLOGY, 2012, 19 (01) : 8 - 8
  • [39] Precision Therapy for Lung Cancer: Tyrosine Kinase Inhibitors and Beyond
    Rajan, Arun
    Schrump, David S.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2015, 27 (01) : 36 - 48
  • [40] Non-receptor tyrosine kinase inhibitors in lung cancer
    Hahn, Olwen
    Salgia, Ravi
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 633 - 642
12345